Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 1 versus 2 weeks of ciprofloxacin for acute pyelonephritis in women
2005-004992-39Phase 4Completed
- Sponsor
- Smittskyddsinstitutet, STRAMA
- Start
- Nov 2005
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ciprofloxacin in acute pyelonephritis (2 arms), sponsored by Smittskyddsinstitutet, STRAMA. Primary endpoint: Therapy failure. Started Nov 2005; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
acute pyelonephritis
Beyond the preview
Go deeper on 2005-004992-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004992-39.